The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients
Venous thromboembolism (VTE) risk is increased in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A key question was whether increased intensity of anticoagulation would help prevent VTE and improve patient outcomes, including transfer to the intensive care unit...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2024/8838308 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850173187111780352 |
|---|---|
| author | Rena Zheng Alexandra Solomon Madeline DiLorenzo Iniya Rajendran Joseph Park Vrushali Dhongade Michael A. Garcia Robert T. Eberhardt John Mark Sloan Janice Weinberg Elizabeth S. Klings |
| author_facet | Rena Zheng Alexandra Solomon Madeline DiLorenzo Iniya Rajendran Joseph Park Vrushali Dhongade Michael A. Garcia Robert T. Eberhardt John Mark Sloan Janice Weinberg Elizabeth S. Klings |
| author_sort | Rena Zheng |
| collection | DOAJ |
| description | Venous thromboembolism (VTE) risk is increased in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A key question was whether increased intensity of anticoagulation would help prevent VTE and improve patient outcomes, including transfer to the intensive care unit (ICU) and mortality. At the start of the coronavirus disease-19 (COVID-19) pandemic, our institution, Boston Medical Center, instituted a VTE risk stratification protocol based on patients’ initial D-dimer levels, medical history, and presence of thrombosis to determine whether they should receive standard-dose prophylaxis, high-dose prophylaxis, or therapeutic anticoagulation. We performed a retrospective observational cohort study examining the association of degree of anticoagulation with outcomes in 915 hospitalized COVID-19 patients hospitalized initially on the general inpatient wards between March 1,, 2020, and June 1, 2020. Patients directly hospitalized in the ICU were excluded. Most, 813 patients (89%), in our cohort were on standard-dose prophylaxis; 32 patients (3.5%) received high-dose prophylaxis; 70 patients (7.7%), were treated with therapeutic anticoagulation. VTE occurred in 45 patients (4.9%), and the overall in-hospital mortality rate was 5.4% (49 deaths). On multivariable analysis of clinical outcomes in relation to type of anticoagulation, in the high-dose prophylaxis group, there was a trend towards increased in-hospital mortality (odds ratio 2.4 (0.8–7.5, 95% CI)) and increased ICU transfer (odds ratio 2.2 (0.9-5.7, 95% CI)). Our results suggest that patients receiving high-dose prophylaxis had more severe disease that was not mitigated by intermediate-dose anticoagulation. |
| format | Article |
| id | doaj-art-d10ef038aebd4b8d894808a8e913b607 |
| institution | OA Journals |
| issn | 1687-9112 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advances in Hematology |
| spelling | doaj-art-d10ef038aebd4b8d894808a8e913b6072025-08-20T02:19:54ZengWileyAdvances in Hematology1687-91122024-01-01202410.1155/2024/8838308The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 PatientsRena Zheng0Alexandra Solomon1Madeline DiLorenzo2Iniya Rajendran3Joseph Park4Vrushali Dhongade5Michael A. Garcia6Robert T. Eberhardt7John Mark Sloan8Janice Weinberg9Elizabeth S. Klings10UMass Chan Medical SchoolEastern Vascular AssociatesNew York University Grossman School of MedicineUniversity of ArizonaBrigham and Women’s HospitalBrigham and Women’s HospitalValley Medical Center Pulmonary & Sleep Disorder ClinicBoston University Chobanian & Avedisian School of MedicineBoston University Chobanian & Avedisian School of MedicineBoston University School of Public HealthBoston University Chobanian & Avedisian School of MedicineVenous thromboembolism (VTE) risk is increased in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A key question was whether increased intensity of anticoagulation would help prevent VTE and improve patient outcomes, including transfer to the intensive care unit (ICU) and mortality. At the start of the coronavirus disease-19 (COVID-19) pandemic, our institution, Boston Medical Center, instituted a VTE risk stratification protocol based on patients’ initial D-dimer levels, medical history, and presence of thrombosis to determine whether they should receive standard-dose prophylaxis, high-dose prophylaxis, or therapeutic anticoagulation. We performed a retrospective observational cohort study examining the association of degree of anticoagulation with outcomes in 915 hospitalized COVID-19 patients hospitalized initially on the general inpatient wards between March 1,, 2020, and June 1, 2020. Patients directly hospitalized in the ICU were excluded. Most, 813 patients (89%), in our cohort were on standard-dose prophylaxis; 32 patients (3.5%) received high-dose prophylaxis; 70 patients (7.7%), were treated with therapeutic anticoagulation. VTE occurred in 45 patients (4.9%), and the overall in-hospital mortality rate was 5.4% (49 deaths). On multivariable analysis of clinical outcomes in relation to type of anticoagulation, in the high-dose prophylaxis group, there was a trend towards increased in-hospital mortality (odds ratio 2.4 (0.8–7.5, 95% CI)) and increased ICU transfer (odds ratio 2.2 (0.9-5.7, 95% CI)). Our results suggest that patients receiving high-dose prophylaxis had more severe disease that was not mitigated by intermediate-dose anticoagulation.http://dx.doi.org/10.1155/2024/8838308 |
| spellingShingle | Rena Zheng Alexandra Solomon Madeline DiLorenzo Iniya Rajendran Joseph Park Vrushali Dhongade Michael A. Garcia Robert T. Eberhardt John Mark Sloan Janice Weinberg Elizabeth S. Klings The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients Advances in Hematology |
| title | The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients |
| title_full | The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients |
| title_fullStr | The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients |
| title_full_unstemmed | The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients |
| title_short | The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients |
| title_sort | association of anticoagulation intensity with outcomes in hospitalized covid 19 patients |
| url | http://dx.doi.org/10.1155/2024/8838308 |
| work_keys_str_mv | AT renazheng theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT alexandrasolomon theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT madelinedilorenzo theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT iniyarajendran theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT josephpark theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT vrushalidhongade theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT michaelagarcia theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT robertteberhardt theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT johnmarksloan theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT janiceweinberg theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT elizabethsklings theassociationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT renazheng associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT alexandrasolomon associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT madelinedilorenzo associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT iniyarajendran associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT josephpark associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT vrushalidhongade associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT michaelagarcia associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT robertteberhardt associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT johnmarksloan associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT janiceweinberg associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients AT elizabethsklings associationofanticoagulationintensitywithoutcomesinhospitalizedcovid19patients |